MSD Animal Health completed the acquisition of Vilsan Pharmaceuticals from Vimar.

MSD Animal Health, which offers innovative veterinary pharmaceuticals and vaccines, services and technologies to prevent, treat and control animal diseases, completed the acquisition of Vilsan Pharmaceuticals, a producer of animal health products, from Vimar, a provider of animal health products and services. Financial terms were not disclosed. “We are very pleased to join with MSD Animal Health to build upon our 30-year commitment to advance the health of animals. Their expertise, commercial reach and worldwide network, combined with our portfolio and production capacity, represents a tremendous opportunity to serve producers and veterinarians in this region,” Burhan Haci, Vilsan Pharmaceuticals CEO.